ibit

World

U.S. and EU Escalate Pressure on Iran with Sanctions Targeting Interior Minister Over Protest Crackdown

The United States, in coordination with European allies, has imposed new sanctions on Iran's Interior Minister and other officials, accusing them of orchestrating a violent suppression of nationwide protests. The measures target assets and travel, reflecting a widening international response to Tehran's handling of domestic unrest.

Jan 30, 2026

Business

Navigating Market Uncertainty: Vanguard's Low-Cost Utility ETF Offers a Defensive Haven for 2026

As equity markets show signs of fatigue after a prolonged bull run, defensive sectors like utilities are gaining attention. The Vanguard Utilities ETF (VPU), with its low cost and stable dividend yield, presents a compelling option for investors seeking to buffer their portfolios against potential volatility.

Jan 30, 2026

Business

Alumis Soars as Psoriasis Drug Hits All Phase 3 Goals, Drawing Bullish Analyst Praise

Clinical-stage biopharma Alumis Inc. (ALMS) is gaining significant Wall Street attention after its lead drug candidate, envudeucitinib, successfully met all endpoints in key Phase 3 trials for plaque psoriasis, prompting multiple analyst upgrades and optimistic price targets.

Jan 30, 2026

Business

UK Industry Faces Compliance Cliff Edge as EU Digital Product Passport Looms

New research reveals a stark preparedness gap among UK manufacturers and wholesalers for the impending EU Digital Product Passport (DPP), with nearly half unaware of the regulation that could bar non-compliant goods from the single market.

Jan 30, 2026

Business

Bitcoin ETFs Bleed $817 Million as Crypto Plunges to Nine-Month Low

A brutal sell-off in Bitcoin, exacerbated by Federal Reserve uncertainty and weak tech earnings, triggered massive withdrawals from U.S. spot Bitcoin ETFs, casting doubt on near-term price targets.

Jan 30, 2026

Business

Bitcoin's 30% Dip: Why the Blue-Chip Crypto Remains the Top $500 Bet for Long-Term Investors

Amid a broad crypto market downturn, Bitcoin's relative resilience and long-term growth narrative make it a standout choice for investors looking to deploy a modest $500, despite the allure of riskier, high-volatility alternatives.

Jan 30, 2026

Business

Election Integrity in Focus: Watchdog Warns of Foreign Funding, Noncitizen Voting Ahead of Midterms

As states finalize legislation before the 2026 elections, a conservative-leaning watchdog group highlights vulnerabilities in the voting system, pushing for reforms to curb foreign influence and clarify citizenship requirements for voters.

Jan 30, 2026

Business

Bitcoin Volatility Surges to 8-Month High as Traders Brace for Turbulence

Bitcoin's volatility gauge spiked sharply during Thursday's sell-off, signaling heightened trader anxiety and a rush for downside protection, though metrics suggest the market is not yet in extreme fear territory.

Jan 30, 2026

Business

Microsoft's AI Bet Pays Off: Q2 Profits Soar 60% to $38.5 Billion as Cloud Demand Accelerates

Microsoft's second-quarter earnings smashed expectations, fueled by a 26% surge in cloud revenue that crossed the $50 billion mark for the first time. The tech giant's aggressive AI investments are now driving significant growth across its enterprise stack.

Jan 30, 2026

Business

United Rentals Caps Record 2025, Eyes Another Year of Growth Fueled by Mega-Projects

United Rentals reported strong Q4 results, driven by data center and power sector demand, and issued 2026 guidance forecasting continued revenue growth. Management highlighted a robust project pipeline while navigating margin pressures.

Jan 30, 2026

Business

Analysts Bullish on BeOne Medicines: Phase 3 Success Fuels $3.8B Revenue Forecast for 2025

Citizens reiterates a 'Market Outperform' rating and $396 price target for BeOne Medicines (ONC), driven by robust Phase 3 trial results in gastric cancer. The firm highlights the company's strong pipeline and cash position as key growth drivers.

Jan 30, 2026

Business

Argenx's Vyvgart Surges Past Sales Forecasts, Fueling Optimism for Autoimmune Portfolio

Biotech firm Argenx SE sees its flagship drug Vyvgart outperform sales expectations in myasthenia gravis and CIDP treatments, with analysts pointing to sustained growth and regulatory momentum as key drivers.

Jan 30, 2026

Business

Sentient (SENT) Bucks Crypto Downtrend with 60% Surge: The Metrics Behind the Rally and Looming Risks

As the broader cryptocurrency market stumbles, Sentient's SENT token has staged a remarkable 60% rally. A deep dive into on-chain and derivatives data reveals the drivers of its resilience—and the significant vulnerabilities that could threaten its gains.

Jan 30, 2026

Business

Bitcoin Retreats Below $90K as $8.8 Billion Options Expiry Looms, Testing Market Resilience

Bitcoin's struggle to hold the $90,000 level intensifies as a massive monthly options expiry approaches, driving traders toward defensive positioning and heightened volatility hedging.

Jan 30, 2026

Business

Vera Therapeutics Sees Major Price Target Hikes as Analysts Bet Big on Its Kidney Disease Drug

Vera Therapeutics (VERA) is drawing bullish attention from Wall Street, with multiple analysts significantly raising price targets following a key competitor's FDA approval and revised revenue forecasts for its lead drug candidate.

Jan 30, 2026

Business

Las Vegas Sands Shares Plunge 14% on Macau Weakness, Casting Shadow Over Recovery Hopes

A disappointing full-year EBITDA performance from its crucial Macau operations triggered a sharp sell-off in Las Vegas Sands stock, underscoring the lingering challenges facing the gaming giant in the wake of China's regulatory crackdown.

Jan 30, 2026

Business

Golden Burden: Soaring Prices Crush Borrowers, Enrich Savers in Vietnam

As global gold prices hit historic highs, Vietnam's deep-rooted culture of gold ownership is creating starkly divided fortunes, turning traditional family loans into crushing debts while minting paper billionaires among long-term holders.

Jan 30, 2026

Business

U.S. Eases Venezuela Oil Sanctions, Opens Door for American Firms to Revive Crude Sector

The Trump administration has issued a broad license allowing U.S. entities to engage in key oil activities in Venezuela, a major sanctions relief step aimed at jumpstarting the nation's crippled energy industry under its new U.S.-backed leadership.

Jan 30, 2026